Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Expert Opinion on Therapeutic Patents|October 30, 2023
Conjugates of monocyclic β-lactams and siderophore mimetics: a patent evaluation (WO2023023393)Alen Krajnc, Stanislav Gobec
Current Opinion in Chemical Biology|April 21, 2019
Will morphing boron-based inhibitors beat the β-lactamases?Alen Krajnc, Pauline A Lang, Tharindi D Panduwawala, et al.
RSC Medicinal Chemistry|January 22, 2021
Cyclic boronates as versatile scaffolds for KPC-2 β-lactamase inhibitionCatherine L Tooke, Philip Hinchliffe, Alen Krajnc, et al.
Chemmedchem|April 1, 2021
Structural Basis of Prolyl Hydroxylase Domain Inhibition by MolidustatWilliam D Figg, Michael A McDonough, Rasheduzzaman Chowdhury, et al.
ACS Infectious Diseases|December 17, 2019
Broad Spectrum β-Lactamase Inhibition by a Thioether Substituted Bicyclic BoronateAnete Parkova, Anka Lucic, Alen Krajnc, et al.
Acta Pharmaceutica (Zagreb, Croatia)|September 16, 2024
Synthesis and biochemical evaluation of new 3-amido-4-substituted monocyclic ß-lactams as inhibitors of penicillin-binding protein(s)Katarina Grabrijan, Nika Strašek Benedik, Alen Krajnc, et al.
Biomolecules|June 18, 2020
Bicyclic Boronates as Potent Inhibitors of AmpC, the Class C β-Lactamase from <i>Escherichia coli</i>Pauline A Lang, Anete Parkova, Thomas M Leissing, et al.
Journal of Medicinal Chemistry|August 2, 2021
High-Throughput Crystallography Reveals Boron-Containing Inhibitors of a Penicillin-Binding Protein with Di- and Tricovalent Binding ModesHector Newman, Alen Krajnc, Dom Bellini, et al.
Pageof 2